Angel Matthew bought TPST
March 24, 2026 · Form 4 insider transaction
Angel Matthew bought 231,482 shares of Tempest Therapeutics, Inc. at $2.16 per share, a transaction worth $500.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 91 days after the transaction.
Footnotes
The combined purchase price per one share of Common Stock and accompanying one warrant to purchase one share of Common Stock was $2.16.; On March 24, 2026, Factor Biosciences Inc. ("Factor") acquired 231,482 shares of common stock, par value $0.001 per share, of Tempest Therapeutics, Inc. ("Common Stock") and warrants to purchase 462,964 shares of Common Stock (the "Warrants"), pursuant to a Securities Purchase Agreement by and between the Issuer, Factor and two institutional investors, dated as of March 20, 2026.; The Reporting Person is the majority stockholder and Chairman of the Board of Directors of Factor and exercises voting and investment power over the shares held by Factor.